Semaxanib

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

3 NDC API

3 NDC API

DOSSIERs // Finished Dosage Forms

20 Dossiers, 1 FDA Orange Book, 12 Europe, 2 Canada, 4 Australia, 1 South Africa

RELATED EXCIPIENT COMPANIES

Suppliers, 12 SPI Pharma, 3 Roquette, 3 Gangwal Chemicals, 2 Pfanstiehl, 2 Actylis, 2 DKSH, 2 BASF, 2 Microlex e.U, 2 Kerry, 2 Seppic, 2 Gangwal Healthcare, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Rochem International Inc, 1 Nanjing Well Pharmaceutical, 1 Ingredion Pharma Solutions, 1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

18 Fillers, Diluents & Binders, 12 Taste Masking, 10 Direct Compression, 10 Chewable & Orodispersible Aids, 6 Parenteral, 4 Solubilizers, 4 Co-Processed Excipients, 3 Disintegrants & Superdisintegrants, 3 Thickeners and Stabilizers, 3 Granulation, 3 Coating Systems & Additives, 2 Topical, 1 API Stability Enhancers, 1 Surfactant & Foaming Agents

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 8 Finished Drug Prices

MARKET PLACE

2 APIs, 3 DOSSIERS // FDF

PATENTS

2 Health Canada Patents

2 Health Canada Patents

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 3 News

Information, Expiry & Status of Health Canada Patents covering Semaxanib.

Semaxanib

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

3 NDC API

DOSSIERs // Finished Dosage Forms

20 Dossiers

1 FDA Orange Book

12 Europe

2 Canada

4 Australia

1 South Africa

RELATED EXCIPIENT COMPANIES

Suppliers

12 SPI Pharma

3 Roquette

3 Gangwal Chemicals

2 Pfanstiehl

2 Actylis

2 DKSH

2 BASF

2 Microlex e.U

2 Kerry

2 Seppic

2 Gangwal Healthcare

1 Shijiazhuang Huaxu Pharmaceutical

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Rochem International Inc

1 Nanjing Well Pharmaceutical

1 Ingredion Pharma Solutions

1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

18 Fillers, Diluents & Binders

12 Taste Masking

10 Direct Compression

10 Chewable & Orodispersible Aids

6 Parenteral

4 Solubilizers

4 Co-Processed Excipients

3 Disintegrants & Superdisintegrants

3 Thickeners and Stabilizers

3 Granulation

3 Coating Systems & Additives

2 Topical

1 API Stability Enhancers

1 Surfactant & Foaming Agents

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

8 Finished Drug Prices

MARKET PLACE

2 APIs

3 DOSSIERS // FDF

PATENTS

2 Health Canada Patents

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow

3 News

Semaxanib

Amgen Canada Inc.

Semaxanib

2346996

250 ┬╡g / 0.5 mL

POWDER FOR SOLUTION

Human

2019-10-22

2013-11-19

1999-10-22

NPLATE

SUBCUTANEOUS

Amgen Canada Inc.

Semaxanib

2346996

500 ┬╡g / 1 mL

POWDER FOR SOLUTION

Human

2019-10-22

2013-11-19

1999-10-22

NPLATE